Stories

Katie Perry’s work as a supervisor for the Mayo Lab Inquiry call center helps ensure that clients get the information they need, when they need it, and smooths the way for tests to be completed without delay.

This Feature Includes: Assessing the contribution of rare variants to complex trait heritability from whole-genome sequence data.

Successful implementation of a new slide scanning and analysis platform across five laboratories represents a significant step forward in Mayo Clinic’s digital pathology program — an initiative that combines advanced technology with human expertise to better serve patients.

This week’s research roundup features: Androgen deprivation therapy use and duration with definitive radiotherapy for localized prostate cancer: an individual patient data meta-analysis.

A Mayo Clinic Laboratories newborn screening panel detects a rare disease and paves the way for life-sustaining treatment.

Topic's Include: Mayo Clinic Q&A podcast: New cases of COVID-19 continue downward trend.

As a client account representative, Heather Van Buskirk uses her problem-solving skills to make sure invoices get paid in a timely manner, so Mayo Clinic Laboratories’ services remain available to providers and their patients.

This week’s research roundup features: Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: An ECOG-ACRIN cancer research group trial (E3311).

Topic's Include: Mayo Clinic expert discusses how COVID-19 vaccination during pregnancy may protect babies after birth, and Mayo Clinic in Rochester to ease visitor restrictions for hospital patients.

This week’s research roundup features: Deep residual inception encoder-decoder network for amyloid PET harmonization.

Topic's Include: Cases down, but Mayo Clinic expert says COVID-19 pandemic isn’t over, and community leaders and Mayo Clinic researchers develop playbook for COVID-19 health equity, future pandemics.

As director of Contract Administration, Cara Ryan’s work spans a diverse range of activities that connect with a variety of groups across the organization, all with a goal of supporting patient care.

This week’s research roundup features: Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial.